Mizuho Securities Remains Bullish on Mallinckrodt (MNK) Following Strong 4Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Mallinckrodt (MNK) Sees Notable Pressure
November 29, 2016 9:52 AM ESTMallinckrodt (NYSE: MNK) is seeing notable weakness following earning this morning. The call is ongoing. Shares are down 6.6%
... MoreBMO Capital Reiterates Outperform on Mallinckrodt (MNK) Following Solid 4Q
November 29, 2016 9:43 AM ESTBMO Capital reiterated an Outperform rating and $92.00 price target on Mallinckrodt plc (NYSE: MNK) following the company's 4Q earnings report. Revenue of $887mn came in ahead of the consensus of 874mn, driven largely by Acthar. EPS were $2.04 vs. the consensus of 1.97.... More
Health stocks boost Wall Street; energy a drag
November 29, 2016 7:33 AM ESTBy Caroline Valetkevitch
(Reuters) - U.S. stocks edged higher on Tuesday as an upbeat outlook from UnitedHealth lifted health insurers, though a sharp drop in oil prices weighed on energy shares and limited the advance.
The day's small gains followed a decline in the market on Monday. Analysts said the post-U.S. election rally may be losing momentum, wit the S&P 500 now up roughly 8 percent for the year to date.
Wall Street has risen sharply following Donald Trump's White House win, helped in part by investor expectations that his plans to increase infrastructure spending,... More
Mallinckrodt (MNK) Tops Q4 EPS by 3c; Therakos Production Issues Noted
November 29, 2016 6:01 AM ESTMallinckrodt (NYSE: MNK) reported Q4 EPS of $2.04, $0.03 better than the analyst estimate of $2.01. Revenue for the quarter came in at $887.2 million versus the consensus estimate of $880.1 million.
H.P. Acthar Gel (repository corticotropin injection) net sales were $327.0 million in the quarter, a 19.3% increase over $274.2 million. Mallinckrodts second largest product, INOMAX (nitric oxide) gas, for inhalation, generated net sales of $126.9 million, up 22.4% over $103.7 million, with constant-currency growth of 22.4%. In the quarter the U.S. Patent and Trademark Office and its Patent Trial and Appeal Board affirmed the validity of multiple INOMAX drug and device... More
Mallinckrodt Plc (MNK) December weekly 57 straddle priced for movement of 9.6%
November 28, 2016 3:10 PM ESTMallinckrodt (NYSE: MNK) December weekly 57 straddle priced for movement of 9.6%
... MoreTrading Radar for 11/29: BNS (BNS), Tiffany (TIF), Autodesk (ADSK), Splunk (SPLK) Report
November 28, 2016 1:30 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
9:00am EST
Case-Shiller 20-City Index - Street sees... MoreMallinckrodt Plc (MNK) volatility increases to into Q4
November 28, 2016 11:39 AM ESTMallinckrodt (NYSE: MNK) December weekly call option implied volatility is at 106, December is at 77; compared to its 52-week range of 34 to 97 into the expected release of Q4 results on November 29.
... More